IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed gross margin
Gross margin is gross profit as a percentage of revenue.
IRadimed's gross margin for the twelve months ending Sep 30, 2026 was 75.5%. For fiscal 2025 it was 76.7%, against 76.9% the year before. The highest annual figure on record is 81.5% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 76.7% | −0.2 |
| FY2024 | Dec 31, 2024 | 76.9% | +0.4 |
| FY2023 | Dec 31, 2023 | 76.5% | −0.9 |
| FY2022 | Dec 31, 2022 | 77.4% | +0.8 |
| FY2021 | Dec 31, 2021 | 76.6% | +2.3 |
| FY2020 | Dec 31, 2020 | 74.3% | −2.8 |
| FY2019 | Dec 31, 2019 | 77.1% | +0.8 |
| FY2018 | Dec 31, 2018 | 76.3% | +0.4 |
| FY2017 | Dec 31, 2017 | 75.9% | −5.2 |
| FY2016 | Dec 31, 2016 | 81.1% | −0.5 |
| FY2015 | Dec 31, 2015 | 81.5% | +3.3 |
| FY2014 | Dec 31, 2014 | 78.3% | +3.4 |
| FY2013 | Dec 31, 2013 | 74.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 76.3% | −1.5 |
| Q2 FY2026 | Jun 30, 2026 | 74.1% | −4.1 |
| Q1 FY2026 | Mar 31, 2026 | 76.5% | +0.4 |
| Q4 FY2025 | Dec 31, 2025 | 75.1% | −1.1 |
| Q3 FY2025 | Sep 30, 2025 | 77.8% | +0.4 |
| Q2 FY2025 | Jun 30, 2025 | 78.2% | +0.0 |
| Q1 FY2025 | Mar 31, 2025 | 76.1% | +0.0 |
| Q4 FY2024 | Dec 31, 2024 | 76.1% | −0.7 |
| Q3 FY2024 | Sep 30, 2024 | 77.4% | −0.3 |
| Q2 FY2024 | Jun 30, 2024 | 78.1% | +2.6 |
| Q1 FY2024 | Mar 31, 2024 | 76.1% | +0.3 |
| Q4 FY2023 | Dec 31, 2023 | 76.9% | +1.4 |
| Q3 FY2023 | Sep 30, 2023 | 77.8% | −0.9 |
| Q2 FY2023 | Jun 30, 2023 | 75.5% | −4.2 |
| Q1 FY2023 | Mar 31, 2023 | 75.7% | −0.4 |
| Q4 FY2022 | Dec 31, 2022 | 75.5% | −2.4 |
| Q3 FY2022 | Sep 30, 2022 | 78.6% | +1.6 |
| Q2 FY2022 | Jun 30, 2022 | 79.7% | +5.0 |
| Q1 FY2022 | Mar 31, 2022 | 76.2% | −0.4 |
| Q4 FY2021 | Dec 31, 2021 | 77.9% | +2.6 |
| Q3 FY2021 | Sep 30, 2021 | 77.1% | +2.5 |
| Q2 FY2021 | Jun 30, 2021 | 74.7% | +2.2 |
| Q1 FY2021 | Mar 31, 2021 | 76.6% | +2.1 |
| Q4 FY2020 | Dec 31, 2020 | 75.3% | +0.5 |
| Q3 FY2020 | Sep 30, 2020 | 74.6% | −3.7 |
| Q2 FY2020 | Jun 30, 2020 | 72.6% | −7.3 |
| Q1 FY2020 | Mar 31, 2020 | 74.5% | −1.2 |
| Q4 FY2019 | Dec 31, 2019 | 74.8% | −1.4 |
| Q3 FY2019 | Sep 30, 2019 | 78.2% | +2.2 |
| Q2 FY2019 | Jun 30, 2019 | 79.9% | +3.1 |
| Q1 FY2019 | Mar 31, 2019 | 75.7% | −0.5 |
| Q4 FY2018 | Dec 31, 2018 | 76.2% | +0.7 |
| Q3 FY2018 | Sep 30, 2018 | 76.0% | −1.0 |
| Q2 FY2018 | Jun 30, 2018 | 76.8% | −0.8 |
| Q1 FY2018 | Mar 31, 2018 | 76.2% | +3.1 |
| Q4 FY2017 | Dec 31, 2017 | 75.5% | −2.7 |
| Q3 FY2017 | Sep 30, 2017 | 77.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 77.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 73.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 78.2% | – |
See a number that looks wrong?